Sign up to save your podcasts
Or
Share Let's Talk Relapsed/Refractory Chronic Lymphocytic Leukemia: Expert Perspectives on Reversible BTK Inhibitors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Let's Talk Relapsed/Refractory Chronic Lymphocytic Leukemia: Expert Perspectives on Reversible BTK Inhibitors
Did you know studies have shown that noncovalent BTK inhibitors are efficacious in patients with covalent BTK inhibitor-pretreated CLL?
Credit available for this activity expires: 4/12/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990418?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape
4.2
2222 ratings
Did you know studies have shown that noncovalent BTK inhibitors are efficacious in patients with covalent BTK inhibitor-pretreated CLL?
Credit available for this activity expires: 4/12/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990418?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current CME
View all
JAMA Editors' Summary
127 Listeners
Medicine and Science from The BMJ
40 Listeners
The Bob Harrington Show
13 Listeners
NEJM This Week
315 Listeners
This Week in Cardiology
852 Listeners
JAMA Clinical Reviews
476 Listeners
AFP: American Family Physician Podcast
693 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
282 Listeners
Frankly Speaking About Family Medicine
252 Listeners
The Curbsiders Internal Medicine Podcast
3,327 Listeners
JAMA Medical News
91 Listeners
Core IM | Internal Medicine Podcast
1,087 Listeners
Annals On Call Podcast
174 Listeners
The Clinical Problem Solvers
510 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
318 Listeners
Medicine and the Machine
59 Listeners
Keeping Current
8 Listeners
Run the List
245 Listeners
The Curious Clinicians
364 Listeners